Growth Metrics

Angiodynamics (ANGO) Gains from Investment Securities (2016 - 2026)

Angiodynamics' Gains from Investment Securities history spans 17 years, with the latest figure at -$1.0 million for Q1 2026.

  • For Q1 2026, Gains from Investment Securities fell 3233.33% year-over-year to -$1.0 million; the TTM value through Feb 2026 reached $132000.0, down 56.86%, while the annual FY2025 figure was $800000.0, 75.82% up from the prior year.
  • Gains from Investment Securities reached -$1.0 million in Q1 2026 per ANGO's latest filing, down from $447000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.6 million in Q4 2022 to a low of -$1.0 million in Q1 2026.
  • Average Gains from Investment Securities over 5 years is $217250.0, with a median of $112500.0 recorded in 2022.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 2075.0% in 2022, then plummeted 3233.33% in 2026.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.6 million in 2022, then crashed by 92.16% to $129000.0 in 2023, then crashed by 192.25% to -$119000.0 in 2024, then skyrocketed by 475.63% to $447000.0 in 2025, then plummeted by 323.71% to -$1.0 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Gains from Investment Securities are -$1.0 million (Q1 2026), $447000.0 (Q4 2025), and -$264000.0 (Q3 2025).